IRCT20180515039672N1已完成3 期
Phase 3 clinical trial for non-inferiority evaluation of efficacy and safety of scorpion antivenom Padra Serum Alborz production vs Razi Vaccine and Serum Research Institute in the treatment of scorpion sting victims age of 2 to 60
Padra Serum Alborz Company0 个研究点目标入组 98 人开始时间: 待定最近更新:
试验速览
- 阶段
- 3 期
- 状态
- 已完成
- 发起方
- 入组人数
- 98
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 2 years 至 60 years（—）
- 性别
- All
入选标准
- •Scorpion sting victims age of 2 to 60
- •Hospital entrance at maximum 6 hours after scorpion sting
- •Signs of systemic scorpion envenomation or having the Indication for Antivenom Infusion
排除标准
- •History of allergic reactions to plasma derived productions
- •History of severe allergic diseases such as atopic asthma
- •Present of systemic diseases such as cardiovascular and kidney diseases
- •Pregnant and nursing women
研究者
相似试验
招募中
3 期
on-inferiority clinical trial to compare efficacy and safety of Pembrolizumab (CinnaGen Co.) versus Keytruda® in patients with metastatic Non-Small Cell Lung Cancer (NSCLC)IRCT20150303021315N29CinnaGen company295
尚未招募
3 期
3-weekly versus weekly cisplatin as chemoradiotehrapy for head and neck cancerCTRI/2012/10/003062Tata memorial Hospital Mumbai300
尚未招募
3 期
Clinical trial to evaluated the efficacy and safety of Maxsulid® (Cosmed) compared to Nisulid® (Aché) medicine in the treatment of postoperative pain of wisdom teeth extraction.RBR-73gfctBrainfarma Indústria Química e Farmacêutica S.A.
进行中（未招募）
1 期
Comparative study to evaluate two different treatments for severe dry eye disease. Amniotic membrane extract versus autologous serum eyedrops.Severe Dry Eye DiseaseMedDRA version: 17.1 Level: LLT Classification code 10013778 Term: Dry eyes System Organ Class: 100000004853EUCTR2011-006287-50-ESClínica Universidad de Navarra/Universidad de Navarra50
已完成
3 期
Phase III Comparative Clinical Trial of Treatment Schedules for Oral UFT/LV Therapy as Postoperative Adjuvant Chemotherapy for Stage IIB/III Colorectal Cancercolorectal cancerJPRN-C000000245Japanese Foundation for Multidisciplinary Treatment of Cancer840